Posts Tagged draw needles

New Blunt Cannula Technology | QD Syringe Systems®

Saturday, April 29th, 2017 | Permalink

New Blunt Cannula Technology

Ready, set, go! QD Syringe Systems, LLC. introduces a revolutionary product to enter the market soon – Quick Draw Syringe™, the world’s first fully functional low dead space basic syringe. The Quick Draw Syringe or QD Syringe is touted as the next generation of basic functional disposable syringes which will completely eliminate the need for the outdated nonfunctional basic luer lock syringe. It’s an easier, safer alternative for medical professionals to use. Our QD Syringe Systems team is currently working on a QD Neutral Displacement Needleless Connector which will enable the quick accessibility of the QD Syringe’s tip but will also allow for basic current luer lock syringes universal ISO 80369 syringe comparability.


“With so many changes in technology, we decided that there was a great need for not just a new disposable syringe but one that vastly improved the function, safety and efficiency of it. And with the rising costs of healthcare, there was also a need for a basic syringe that was cost-effective. The QD Syringe is faster, more efficacious and simplifies the process of withdrawing medication from a rubber stopper vial and injecting it into a patient or within seconds, immediately delivers medication into a patient’s luer access split septum,” says Christopher Green, CEO and co-founder of QD Syringe Systems. QD Syringe is simple – open the package and it’s fully functional.


Basic syringes nationwide haven’t had a design change in decades and while they work, they aren’t as effective as they could be. The basic Luer Lock syringe is essentially dependent on two needles with hubs, one to draw the medication into its chamber and the second to deliver the medication to its intended patient. Current basic syringes waste costly medications, up to 42 microliters in its separate draw needle and up to 42 microliters left in the vial and often leaving up to 84 microliters of residual medication volume in the syringe tip and hub after patient delivery. This means up to 168 microliters of expensive medication is wasted. With the GlyFlo Technology™, the QD syringe has a uniquely patented and integrated cone-shaped tip with channels which allows the QD Syringe to extract all of the medication necessary from rubber stopper vials and to deliver that costly medicine to patients effectively. “The QD Syringe leaves as little as 18 microliters of residual volume from draw to patient delivery, which drastically cuts the waste of costly medications by 89.5%. This is a massive money-saving benefit to the healthcare industry and consumers,” says Christopher Green.


Because of the high dead space in current basic syringes, blood can linger on the tip and inside of its hub which has been shown to encapsulate dangerous living pathogens for many weeks. However, the QD Syringe has a blunt tip with bilateral drying channels (like an inside out needle), causing blood not to pool which makes it much safer for medical experts and reduces the spread of infectious diseases. In addition, the QD Syringe can access both pre-slit, non-pre-slit injection receptacles and has its own ultra sharp steel needle with hub which mates over the cone-shaped GlyFlo tip for immediate patient access.


Video: QD Syringe Drawing Medication From a Vial
Video: QD Syringe Delivering IV Injection through the BD Q-Syte™ Luer Access Split Septum
Video: QD Syringe Drawing Medication From a Vial & Injecting a Patient


© 2017 QD Syringes Systems ~ The QD Syringe is a patented product registered with the U.S. Patent Office.

For More information Contact:

Christopher Green at 954-655-4145


Syringes are a Surprising Source of Wasted Medication

Monday, November 14th, 2016 | Permalink


Syringes are a surprising source of wasted medication

Better syringe design can save thousands of dollars per year

(Chapel Hill, N.C., June 6) – When medicine is injected, a little bit of it stays behind in the syringe. It’s not much, but depending on syringe design and the cost of the drug, this waste — or dead space — can add up to as much as $2,300 per year for a patient, according to a new study from researchers at the University of North Carolina at Chapel Hill and RTI International.

Syringe dead space is the leftover fluid that remains inside the syringe after the plunger is fully depressed. In syringes with a lot of dead space, the leftover amount averages to three percent of the volume of the medication dose. In syringes with a low-dead-space design, the volume of leftover medication averages 10 times less at 0.3 percent.

“It is a difference of fractions of a milliliter, but when some of these medications cost more than $20,000 a month, it adds up,” said Christine Oramasionwu, lead author of the study and an assistant professor in the nation’s No. 1 ranked UNC Eshelman School of Pharmacy. “Low-dead-space design, like those with an integrated needle or a cone-shaped plunger, should be adopted as the industry standard for all syringes in order to reduce preventable and expensive medication waste.”

UNC-Chapel Hill and RTI researchers, whose work is reported in the June 6 issue of JAMA Internal Medicine, identified 17 medications administered using high-dead-space syringes and seven using low-dead-space syringes. The total volume of the injection ranged from one-fourth to five milliliters for high-dead-space medications and 0.08 to one milliliters for low-dead-space medications. The median cost for a month’s supply of medication packaged in high-dead-space syringes was $4,443 and $3,412 for low-dead-space syringes.

The median value of the wasted medicine per dose was $5 for high-dead-space medications and about fifty cents for low-dead-space medications. Over one year, the cost of the waste for high-dead-space medications ranged from $558 to $2,329 (a median value of $1,638) compared to $68 to $205 (a median value of $125) for low-dead-space medications.

The researchers reported the median, or middle value, of most monetary ranges because of the high variability of cost among the relatively small number of medications included in the study. The high and low price for a 30-day supply of the 17 high-dead-space medications was $50 and $20,552. The high and low price for a 30-day supply of the seven low-dead-space medications was $716 and $29,728.


About the University of North Carolina at Chapel Hill

The University of North Carolina at Chapel Hill, the nation’s first public university, is a global higher education leader known for innovative teaching, research and public service. A member of the prestigious Association of American Universities, Carolina regularly ranks as the best value for academic quality in U.S. public higher education. Now in its third century, the University offers 77 bachelor’s, 113 master’s, 68 doctorate and seven professional degree programs through 14 schools and the College of Arts and Sciences. Every day, faculty – including two Nobel laureates – staff and students shape their teaching, research and public service to meet North Carolina’s most pressing needs in every region and all 100 counties. Carolina’s more than 308,000 alumni live in all 50 states and 150 countries. More than 167,000 live in North Carolina.

 UNC Communications and Public Affairs contact: Thania Benios, (919) 962-8596,

UNC Eshelman School of Pharmacy contact: David Etchison, (919) 966-7744,






How Many Steps Does It Take To Draw Medicine Into A Syringe Then…

Thursday, December 8th, 2011 | Permalink

How Many Steps Does It Take To Draw Medicine Into A Syringe Then Deliver It To A Patient?

Visit site:
How Many Steps Does It Take To Draw Medicine Into A Syringe Then…

Contact Us

Click or drag a file to this area to upload.